{
    "code": "02018979",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02018979",
    "time": "2022-02-11 09:26:53",
    "許可證字號": "衛署藥輸字第018979號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/03\/04",
    "發證\/登錄日期": "102\/03\/24",
    "許可證種類": "製　劑",
    "舊證字號": "02014868",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00201897900",
    "中文品名": "敏立舒注射液",
    "英文品名": "MILLISROL INJECTION",
    "適應症": "手術中或其前後高血壓情況之血壓控制、急性心肌梗塞導致之鬱血性心衰竭、有機硝酸鹽類或阻斷劑未產生反應之狹心症、外科手術時用以控制低血壓",
    "劑型": "270注射劑",
    "包裝": "10毫升安瓿瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "NITROGLYCERIN",
    "限制項目": "02輸　入",
    "申請商名稱": "1435301100  台灣日化股份有限公司",
    "申請商地址": "台北市中正區忠孝東路二段88號9樓",
    "主製造廠": [
        {
            "": "JAPAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412200500",
            "成分名稱": "NITROGLYCERIN",
            "含量描述": "",
            "含量": "0.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Millisrol上傳實體外觀-106-06-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02018979&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Millisrol上傳仿單-106-06-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02018979&Seq=003&Type=9"
        },
        {
            "title": "MIL_PI(TW)_Page 2(A3)___20110721.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02018979&Seq=002&Type=9"
        },
        {
            "title": "Millisrol上傳外盒-106-06-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02018979&Seq=004&Type=8"
        },
        {
            "title": "背___20110721.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02018979&Seq=003&Type=8"
        }
    ]
}